350 rub
Journal Technologies of Living Systems №3 for 2013 г.
Article in number:
The clinical significance of cell proliferation determination in primary and metastatic neuroendocrine tumors of the pancreas
Keywords: neuroendocrine tumor pancreas immunohistochemistry proliferative activity
Authors:
V.V. Delektorskaya, N.A. Kozlov, G.Yu. Chemeris
Abstract:
A retrospective clinical and morphological analysis of 72 primary pancreatic neuroendocrine tumors and 32 synchronous and metachronous metastases of these tumors in the liver are presented. The aim of the study was to compare the values of the Ki67 proliferation index in primary and metastatic tumors to evaluate the clinical significance of immunohistochemical determination of the indicator in metastases in the liver. It is shown that the Ki67 index may change in the course of tumor progression, with the synchronous and/or metachronous metastases in the liver, having the typical well differentiated histological structure, do not always repeat the potential of malignancy of primary neoplasms. Increase in the level of the proliferative activity of cells in 2-4 times in comparison with the initial tumor observed in 9 (27.3%) metastases in the liver, with the significant growth of the Ki67 index in the cells of the secondary tumor foci in 6 patients in metastatic group led to an overestimation of the pancreatic neuroendocrine tumor grade (criterion G). Thus, the results of the study show that the increase in the level of Ki67 expression in metastases compared with the primary tumor should be considered as an adverse factor for the progression of the disease and taken into account in assessing the degree of malignancy of tumors and choose the option of further drug treatment of metastatic liver lesions.
Pages: 53-59
References
  1. Adsay V.Ki67 labeling index in neuroendocrine tumors of the gastrointestinal and pancreatobiliary tract: to count or not to count is not the question, but rather how to count // Am. J. Surg. Pathol. 2012. V. 36. № 12. P. 1743-1746.
  2. Amador Cano A., García F., Espinoza A. et al.Nonfunctional neuroendocrine tumor of the pancreas: Case report and review of the literature // Int. J. Surg. Case. Rep. 2013. V. 4. № 2. P. 225 - 228.
  3. Anlauf M.,Gerlach P., Schott M. et al.Pathology of neuroendocrine neoplasms // Chirurg. 2011. V. 82. №7. P. 567 - 573.
  4. Boninsegna L.,Panzuto F.,Partelli S.et al.Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections // Eur. J. Cancer.2012. V. 48. № 11. P.1608 - 1615.
  5. Bosman F.T., Carneiro F.T., Hrubon R.H. et al. (Eds). World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System // IARC Press: Lyon, France. 2010.
  6. Couvelard A.Ki67 and neuroendocrine tumors // Ann. Pathol.2011. V. 31. Suppl. 5. P. 55 - 56.
  7. Couvelard A., Deschamps L., Ravaud P. et al.Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors // Mod. Pathol. 2009. V. 22. № 2. P. 273 - 281.
  8. Dhall D., Mertens R., Bresee C. et al. Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors // Hum. Pathol. 2012. V. 43. № 4. R. 489 - 495.
  9. Jamali M., Chetty R. Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining // Endocr. Pathol. 2008. V. 19. № 4.  P. 282 - 288.
  10. Klöppel G.Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms // Endocr. Relat. Cancer. 2011. V. 18. Suppl. 1. P. 1 - 16.
  11. Klimstra D.S., Modlin I.R., Adsay N.V. et al. Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set // Am. J. Surg. Pathol. 2010. V. 34. № 3.  P. 300 - 313.
  12. Krampitz G.W., Norton J.A., Poultsides G.A. et al. Lymph nodes and survival in pancreatic neuroendocrine tumors // Arch. Surg. 2012.  V. 147. № 9. R. 820 - 827.
  13. Oh T.G.,Chung M.J.,Park J.Y. et al.Prognostic factors and characteristics of pancreatic neuroendocrine tumors: single center experience // Yonsei Med J.2012. V. 53. № 5. P. 944 - 951.
  14. Palazzo M., Lombard-Bohas C., Cadiot G. et al. Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors // Eur. J. Gastroenterol. Hepatol.2013. V. 25. № 2.
    P. 232 - 238.
  15. Panzuto F.,Boninsegna L.,Fazio N.et al.Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression // J. Clin. Oncol.2011.  V. 29. № 17. P. 2372 - 2377.
  16. Remes S.M., Tuominen V.J., Helin H. et al. Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices // Am. J. Surg. Pathol.2012. V. 36. № 9. P. 1359 - 1363.
  17. Rindi G., Kloppel G., Alhman H. et al.TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system // Virchows Arch. 2006. V. 449. P. 393 - 401.
  18. Scarpa A., Mantovani W.,Capelli P. et al. Pancreatic endocrine tumors: improved TNM staging and
    histopathological grading permit a clinically efficient prognostic stratification of patients // Mod. Pathol. 2010.  V. 23. № 6. P. 824 - 833.
  19. Strosberg J.,Nasir A., Coppola D.et al.Correlation between grade and prognosis in metastatic gastroenteropancreaticneuroendocrine tumors // Hum. Pathol. 2009. V. 40. № 9.
    P. 1262 - 1268.
  20. Tang L.H.,Gonen M.,Hedvat C. et al.Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods // Am. J. Surg. Pathol.2012. V. 36. № 12. P. 1761 - 1770.
  21. Yang Z., Tang L.H., Klimstra D.S. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification // Am. J. Surg. Pathol.2011. V. 35. № 6. R. 853 - 860.
  22. Yao J.C., Hassan M., Phan A. et al.One hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Review //
    J. Clin. Oncol. 2008. V. 26. № 18. P. 3063 - 3072.